Biogen Inc (NASDAQ:BIIB)

319.44
Delayed Data
As of 4:00pm ET
 +2.71 / +0.86%
Today’s Change
249.17
Today|||52-Week Range
388.67
+0.27%
Year-to-Date

Today’s Trading

Previous close316.73
Today’s open317.94
Day’s range310.99 - 321.11
Volume928,034
Average volume (3 months)1,207,005
Market cap$63.6B
Data as of 4:00pm ET, 12/10/2018

Growth & Valuation

Earnings growth (last year)-29.57%
Earnings growth (this year)+18.41%
Earnings growth (next 5 years)+6.46%
Revenue growth (last year)+7.81%
P/E ratio20.7
Price/Sales6.17
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+1.64+0.51%
GILDGilead Sciences-0.66-0.97%
TLRYTilray Inc-3.11-3.10%
NBIXNeurocrine Bioscienc...+1.63+1.94%
Data as of 4:15pm ET, 12/10/2018

Financials

Next reporting dateJanuary 30, 2019
EPS forecast (this quarter)$6.73
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts